中华创伤杂志(英文版)(Chinese Journal of Traumatology)(可网站投稿)

《中华创伤杂志(英文版)》(Chinese Journal of Traumatology)(双月刊),杂志于1998年创办,经新闻出版总署批准的正规刊物,是由中华医学会主办,中华医学会创伤学分会承办的英文高级学术刊物,是中华医学会系列杂志之一,主要对外报道我国创伤学及相关学科的成果及进展,全面反映我国创伤医学的成就与水平,促进和指导我国创伤学研究的发展,提高临床救治水平;同时将国外相应领域进展及动态介绍给读者。它使中国的创伤医学走向世界,使外国读者了解中国,促进国内外创伤医学的交流与合作。本刊于1998年创刊,国内外公开发行,双月刊。本刊设有论著、研究报告、综述、述评、病例报告、会议纪要、书评、读者来信等栏目。

本刊特点:CSCD核心期刊(2023-2024), 科技核心期刊(2024自然科学),目次收录(维普),目次收录(万方),目次收录(知网),外文期刊,第二批认定学术期刊,

中华创伤杂志(英文)杂志封面

期刊基本信息

出版周期:双月刊 级别:核心期刊
主管部门:中国科学技术协会
主办单位:中华医学会
编辑部:《中华创伤杂志(英文版)》编辑部
中国国内刊号:CN50-1115/R
国际标准刊号:ISSN 1008-1275
知网复合影响因子:0.758
知网综合影响因子:0.615

杂志社联系方式

地址:重庆市渝中区大坪长江支路10号
邮编:400042
电话:023-68757483;023-68767489
刊内微信公众号:中华创伤杂志英文版
官网邮箱:CJT@cjtrauma.com
官网邮箱:cjt@cmaph.org
官方网站:https://mednexus.org/journal/cjt

杂志征稿投稿要求

《中华创伤杂志(英文)》投稿须知

Instructions for Authors

官网信息】

Introduction

Types of paper

Chinese Journal of Traumatology (CJT) is a bimonthly peer reviewed journal, publishing original research articles, technical advances and study protocols in medical science or clinical practice concerning trauma. The journal welcomes contributions on all aspects of trauma and critical care. The article type includes: original articles, latest or important laboratory findings, novel and effective solutions to trauma patients, comments, reviews, case reports, letters to the editor, worldwide meeting reports, etc.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

Ethics in publishing

Please see our information on Ethics in publishing.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. When coding terminology is used, we recommend to avoid offensive or exclusionary terms such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and (self-) explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

……

更多详情:

https://mednexus.org/journal/cjt/authors/instructions

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/14632

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年10月21日 下午9:07
下一篇 2024年10月21日 下午9:07

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息